Previous Article | Next Article 
J Virol, February 1998, p. 1600-1605, Vol. 72, No. 2
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
CD4+-T-Cell and
CD20+-B-Cell Changes Predict Rapid Disease
Progression after Simian-Human Immunodeficiency Virus Infection
in Macaques
Krista K.
Steger,1
Marta
Dykhuizen,2
Jacque L.
Mitchen,2
Paul W.
Hinds,2
Brenda L.
Preuninger,1
Marianne
Wallace,1
James
Thomson,2
David C.
Montefiori,3
Yichen
Lu,4 and
C. David
Pauza1,2,*
Department of Pathology and Laboratory
Medicine, University of Wisconsin Medical
School,1 and
Wisconsin Regional Primate
Research Center,2 Madison, Wisconsin 53706;
Duke University, Durham, North Carolina
277103; and
Institute for International
Vaccine Development, Cambridge, Massachusetts 021384
Received 16 July 1997/Accepted 4 November 1997
Simian-human immunodeficiency virus 89.6PD (SHIV89.6PD)
was pathogenic after intrarectal inoculation of rhesus macaques.
Infection was achieved with a minimum of 2,500 tissue culture
infectious doses of cell-free virus stock, and there was no evidence
for transient viremia in animals receiving subinfectious doses by the
intrarectal route. Some animals experienced rapid progression of
disease characterized by loss of greater than 90% of circulating CD4+ T cells, sustained decreases in CD20+ B
cells, failure to elicit virus-binding antibodies in plasma, and high
levels of antigenemia. Slower-progressing animals had moderate but
varying losses of CD4+ T cells; showed increases in
circulating CD20+ B cells; mounted vigorous responses to
antibodies in plasma, including neutralizing antibodies; and had low or
undetectable levels of antigenemia. Rapid progression led to death
within 30 weeks after intrarectal inoculation. Plasma antigenemia at 2 weeks after inoculation (P
0.002), B- and T-cell
losses (P
0.013), and failure to seroconvert
(P
0.005) were correlated statistically with rapid
progression. Correlations were evident by 2 to 4 weeks after
intrarectal SHIV inoculation, indicating that early events in the
host-pathogen interaction determined the clinical outcome.
*
Corresponding author. Mailing address: Department of
Pathology and Laboratory Medicine, 1300 University Ave., Room 505, Service Memorial Institute, Madison, WI 53706. Phone: (608) 262-9147. Fax: (608) 262-9148. E-mail: cdpauza{at}facstaff.wisc.edu.
Publication 37-030 from the Wisconsin Regional Primate Research
Center.
This article has been cited by other articles:
-
Picker, L. J., Hagen, S. I., Lum, R., Reed-Inderbitzin, E. F., Daly, L. M., Sylwester, A. W., Walker, J. M., Siess, D. C., Piatak, M. Jr., Wang, C., Allison, D. B., Maino, V. C., Lifson, J. D., Kodama, T., Axthelm, M. K.
(2004). Insufficient Production and Tissue Delivery of CD4+ Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection. JEM
200: 1299-1314
[Abstract]
[Full Text]
-
Potula, R., Dhillion, N., Sui, Y., Zien, C. A., Funa, K., Pinson, D., Mayo, M. S., Singh, D. K., Narayan, O., Buch, S.
(2004). Association of Platelet-Derived Growth Factor-B Chain with Simian Human Immunodeficiency Virus Encephalitis. Am. J. Pathol.
165: 815-824
[Abstract]
[Full Text]
-
Chen, Z., Huang, Y., Zhao, X., Skulsky, E., Lin, D., Ip, J., Gettie, A., Ho, D. D.
(2000). Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina). J. Virol.
74: 6501-6510
[Abstract]
[Full Text]
-
Giavedoni, L. D., Velasquillo, M. C., Parodi, L. M., Hubbard, G. B., Hodara, V. L.
(2000). Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells from Rhesus Macaques during Acute Infection with Pathogenic Simian Immunodeficiency Virus. J. Virol.
74: 1648-1657
[Abstract]
[Full Text]
-
Crawford, J. M., Earl, P. L., Moss, B., Reimann, K. A., Wyand, M. S., Manson, K. H., Bilska, M., Zhou, J. T., Pauza, C. D., Parren, P. W. H. I., Burton, D. R., Sodroski, J. G., Letvin, N. L., Montefiori, D. C.
(1999). Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus. J. Virol.
73: 10199-10207
[Abstract]
[Full Text]
-
Wallace, M., Waterman, P. M., Mitchen, J. L., Djavani, M., Brown, C., Trivedi, P., Horejsh, D., Dykhuizen, M., Kitabwalla, M., Pauza, C. D.
(1999). Lymphocyte Activation during Acute Simian/Human Immunodeficiency Virus SHIV89.6PD Infection in Macaques. J. Virol.
73: 10236-10244
[Abstract]
[Full Text]
-
Buge, S. L., Murty, L., Arora, K., Kalyanaraman, V. S., Markham, P. D., Richardson, E. S., Aldrich, K., Patterson, L. J., Miller, C. J., Cheng, S.-M., Robert-Guroff, M.
(1999). Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251. J. Virol.
73: 7430-7440
[Abstract]
[Full Text]
-
Gallo, R. C.
(1999). Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine. Proc. Natl. Acad. Sci. USA
96: 8324-8326
[Full Text]
-
Yin, C., Wu, M. S., Pauza, C. D., Salvato, M. S.
(1999). High Major Histocompatibility Complex-Unrestricted Lysis of Simian Immunodeficiency Virus Envelope-Expressing Cells Predisposes Macaques to Rapid AIDS Progression. J. Virol.
73: 3692-3701
[Abstract]
[Full Text]
-
Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., Lu, Y., Robb, M. L., Katinger, H., Birx, D. L.
(1999). Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies. J. Virol.
73: 4009-4018
[Abstract]
[Full Text]
-
Shinohara, K, Sakai, K, Ando, S, Ami, Y, Yoshino, N, Takahasi, E, Someya, K, Suzaki, Y, Nakasone, T, Sasaki, Y, Kaizu, M, Lu, Y, Honda, M
(1999). A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey. J. Gen. Virol.
80: 1231-1240
[Abstract]
-
Steger, K. K., Waterman, P. M., Pauza, C. D.
(1999). Acute Effects of Pathogenic Simian-Human Immunodeficiency Virus Challenge on Vaccine-Induced Cellular and Humoral Immune Responses to Gag in Rhesus Macaques. J. Virol.
73: 1853-1859
[Abstract]
[Full Text]
-
Lewis, M. G., Yalley-Ogunro, J., Greenhouse, J. J., Brennan, T. P., Jiang, J. B., VanCott, T. C., Lu, Y., Eddy, G. A., Birx, D. L.
(1999). Limited Protection from a Pathogenic Chimeric Simian-Human Immunodeficiency Virus Challenge following Immunization with Attenuated Simian Immunodeficiency Virus. J. Virol.
73: 1262-1270
[Abstract]
[Full Text]
-
Pauza, C. D., Trivedi, P., Wallace, M., Ruckwardt, T. J., Le Buanec, H., Lu, W., Bizzini, B., Burny, A., Zagury, D., Gallo, R. C.
(2000). Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Natl. Acad. Sci. USA
97: 3515-3519
[Abstract]
[Full Text]